{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T15:36:18Z","timestamp":1768923378257,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.yebeh.2012.03.005","type":"journal-article","created":{"date-parts":[[2012,4,12]],"date-time":"2012-04-12T13:37:34Z","timestamp":1334237854000},"page":"138-140","source":"Crossref","is-referenced-by-count":13,"title":["Vigabatrin-induced forced normalization and psychosis \u2014 Prolongated termination of behavioral symptoms but persistent antiepileptic effect after withdrawal"],"prefix":"10.1016","volume":"24","author":[{"given":"Peter","family":"Weber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Dill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre N.","family":"Datta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2012.03.005_bb0005","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1528-1167.2008.01988.x","article-title":"Vigabatrin: 2008 update","volume":"50","author":"Willmore","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2012.03.005_bb0010","series-title":"Antiepileptic drugs","first-page":"855","author":"Vigabatrin","year":"2002"},{"key":"10.1016\/j.yebeh.2012.03.005_bb0015","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/j.1528-1167.2008.01589.x","article-title":"Vigabatrin in the treatment of childhood epilepsy: a retrospective chart review of efficacy and safety profile","volume":"49","author":"Camposano","year":"2008","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.yebeh.2012.03.005_bb0020","first-page":"CD007302","article-title":"Vigabatrin for refractory partial epilepsy","author":"Hemming","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.yebeh.2012.03.005_bb0025","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1528-1167.2008.01728.x","article-title":"Cerebral MRI abnormalities associated with vigabatrin therapy","volume":"50","author":"Pearl","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2012.03.005_bb0030","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1053\/ejpn.2001.0402","article-title":"The long-term use of vigabatrin and lamotrigine in patients with severe childhood onset epilepsy","volume":"5","author":"Kluger","year":"2001","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.yebeh.2012.03.005_bb0035","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.seizure.2004.12.001","article-title":"The use of lamotrigine, vigabatrin, and gabapentin as add-on therapy in intractable epilepsy of childhood","volume":"14","author":"McDonald","year":"2005","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2012.03.005_bb0040","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0140-6736(98)10531-7","article-title":"Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study","volume":"354","author":"Chadwick","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2012.03.005_bb0045","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1053\/seiz.2000.0405","article-title":"Psychiatric symptoms after therapy with new antiepileptic drugs: psychopathological and seizure related variables","volume":"9","author":"Trimble","year":"2000","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2012.03.005_bb0050","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0140-6736(94)91562-8","article-title":"Bipolar affective psychosis after vigabatrin","volume":"343","author":"Naumann","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2012.03.005_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0404.1996.tb00161.x","article-title":"Psychotic and severe behavioural reactions with vigabatrin: a review","volume":"93","author":"Ferrie","year":"1996","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2012.03.005_bb0060","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1212\/WNL.53.7.1503","article-title":"Psychiatric adverse events during vigabatrin therapy","volume":"53","author":"Levinson","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2012.03.005_bb0065","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1600-0404.1999.tb07335.x","article-title":"Vigabatrin use in psychotic epileptic patients: report of a prospective pilot study","volume":"99","author":"Veggiotti","year":"1999","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2012.03.005_bb0070","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1600-0404.1997.tb00094.x","article-title":"Vigabatrin and psychosis: is there a true correlation?","volume":"95","author":"Veggiotti","year":"1997","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2012.03.005_bb0075","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1525-5050(02)00052-5","article-title":"Forced normalization at the interface between epilepsy and psychiatry","volume":"3","author":"Krishnamoorthy","year":"2002","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2012.03.005_bb0080","first-page":"121","article-title":"Some clinical Electroencephalogr correlations in epileptic psychoses (twilight states) EEG","volume":"5","author":"Landolt","year":"1953","journal-title":"Clin Neurophysiol"},{"issue":"Suppl. 10","key":"10.1016\/j.yebeh.2012.03.005_bb0085","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1111\/j.1528-1157.1999.tb00886.x","article-title":"Forced normalization: clinical and therapeutic relevance","volume":"40","author":"Krishnamoorthy","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2012.03.005_bb0090","unstructured":"Tellenbach H Epilepsie als Anfalsleiden und als Psychose, Nervenarzt 1965;36:190\u2013202."},{"issue":"Suppl. 6","key":"10.1016\/j.yebeh.2012.03.005_bb0095","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1002\/ana.10626","article-title":"Vigabatrin and newer interventions in succinic semialdehyde dehydrogenase deficiency","volume":"54","author":"Gropman","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2012.03.005_bb0100","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1136\/jnnp.55.9.758","article-title":"Effects of vigabatrin on striatal dopamine receptors: evidence in humans for interactions of GABA and dopamine systems","volume":"55","author":"Ring","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505012001278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505012001278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,24]],"date-time":"2018-11-24T05:27:09Z","timestamp":1543037229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505012001278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S1525505012001278"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2012.03.005","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}